Bicycle Therapeutics(DE:50BA)
€3.28+0.06 (+1.86%)
DE:50BA
Bicycle Therapeutics earnings date
€3.28
At close:+0.06 (+1.86%)
Bicycle Therapeutics (50BA) Q2 2023 Earnings Report
1 Followers
DE:50BA Q2 2023 EPS Results
- Actual EPS
- -EUR 1.26
- Consensus EPS
- -EUR 1.07
- Beat/Miss
- Missed by -EUR 0.19
- One Year Ago EPS
- -EUR 0.81
DE:50BA Q2 2023 Revenue Results
- Actual Revenue
- EUR 10.24M
- Expected Revenue
- EUR 5.17M
- Beat/Miss
- Beat by +EUR 5.07M
- YoY Revenue Growth
- +163.45%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/03/2023
- Time
- Before Open
- Conference Call
- Thursday, August 3, 2023
DE:50BA Upcoming Earnings
Bicycle Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:50BA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.39- | -0.26 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.36-0.13 | -0.76 | 82.35% (+0.63) | |
| Jul 30, 2026 | 2026 (Q2) | -0.52-0.64 | -1.02 | 36.84% (+0.38) | |
| Apr 30, 2026 | 2026 (Q1) | -0.56-0.78 | -0.79 | 1.14% (+0.01) | |
| Mar 17, 2026 | 2025 (Q4) | -0.84-0.26 | -0.67 | 61.33% (+0.41) | |
| Oct 30, 2025 | 2025 (Q3) | -0.97-0.76 | -0.66 | -14.86% (-0.10) | |
| Aug 08, 2025 | 2025 (Q2) | -0.85-1.02 | -0.69 | -48.05% (-0.33) | |
| May 01, 2025 | 2025 (Q1) | -0.75-0.79 | -0.56 | -41.94% (-0.23) | |
| Feb 25, 2025 | 2024 (Q4) | -0.77-0.67 | -1.04 | 35.34% (+0.37) | |
| Oct 31, 2024 | 2024 (Q3) | -0.71-0.66 | -1.13 | 41.27% (+0.47) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
